Showing results (61-70 of 186) with videos related to
Sort By:
Pageof 19
Investigational New Drugs|May 1, 1990
Hypersensitivity reactions to trimetrexateJ L Grem, S A King, M E Costanza, et al.Journal of the National Cancer Institute|October 19, 1988
Correlates of severe or life-threatening toxic effects from trimetrexateJ L Grem, S S Ellenberg, S A King, et al.Journal of the National Cancer Institute|July 6, 1988
The role of methotrexate in osteosarcomaJ L Grem, S A King, R E Wittes, et al.Cancer|July 1, 1976
Fourteen-year remission of acute leukemia in a patient exposed to thorotrastJ Mabry, H Gralnick, P P CarboneAdvances in Experimental Medicine and Biology|January 1, 1993
Dose-dependent inhibition of aspartate carbamoyltransferase in peripheral blood mononuclear cells in patients receiving N-(phosphonacetyl)-L-aspartateJ L Grem, N McAtee, J C Drake, et al.Leukemia Research|January 1, 1991
Modulation of cytosine arabinoside toxicity by 3-deazauridine in a murine leukemia modelJ L Grem, J Plowman, L Rubinstein, et al.Biochemical Pharmacology|July 29, 1999
Sequence-dependent antagonism between fluorouracil and paclitaxel in human breast cancer cellsJ L Grem, D Nguyen, B P Monahan, et al.Cancer Chemotherapy and Pharmacology|May 10, 2000
Identification and proposed mechanism of action of thymidine kinase inhibition associated with cellular exposure to camptothecin analogsD M Voeller, J L Grem, Y Pommier, et al.Biochemistry|May 11, 1993
Specific binding of human dihydrofolate reductase protein to dihydrofolate reductase messenger RNA in vitroE Chu, C H Takimoto, D Voeller, et al.Cancer Chemotherapy and Pharmacology|January 1, 1989
Hypersensitivity reactions to deoxycoformycinP J O'Dwyer, S A King, E Eisenhauer, et al.Pageof 19